\
&
Contact us
\
&
Contact us
Starts in 4 days from now
LocationOnline
ProgrammesThis online information day aims to inform (potential) applicants about the destinations and topics included in the NEB Facility part of the Horizon Europe ‘main’ work programme for 2025.
The event will be live streamed on the New European Bauhaus website. No registration is required to follow the live stream. You can however fill out this form by 1 June 2025 to receive a reminder about the event.
Ahead of the event, participants are advised to watch the pre-recorded presentations (soon available) and to send your questions in advance. Questions can be submitted via Sli.do by using #NEBFacilityInfoday25, so that they can be answered fully and in priority during the live event.
More information on this event can be found here.
In addition to this info session a matchmaking event on the 2025 NEB Facility calls will be organized the next day on 5 June 2025. More information can be found here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space Digital Europe AI Continent Defence Space
Digital, Industry & Space Climate, Energy, Mobility EIC EIE
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
